Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page

Citigroup Analysts Slash Their Forecasts Following Q3 Results

by Avi Kapoor | Oct 14, 2026

Citigroup Inc. (NYSE:C) on Tuesday posted better-than-expected third-quarter results. Citigroup reported revenue, net of interest expense, of $23.85...

Michael Dell Warns Memory Shortage Could Be a ‘Four-Year Problem’

by Daragh Thomas | Oct 14, 2026

Dell Technologies Inc. (NYSE:DELL) CEO Michael Dell warned that semiconductor shortages could worsen in 2027, suggesting memory supply constraints...

These Analysts Cut Their Forecasts On Johnson & Johnson After Q3 Results

by Avi Kapoor | Oct 14, 2026

Johnson & Johnson (NYSE:JNJ) on Tuesday reported upbeat third-quarter results and raised its full-year guidance. Adjusted earnings fell 7.5%...

Arrowhead Pharmaceuticals Advances Alzheimer’s Drug Push With Promising Early Clinical Results

by Vandana Singh | Oct 14, 2026

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) on Wednesday shared interim data from an ongoing Phase 1/2a clinical trial for ARO-MAPT, an...

Nasdaq Dips Over 400 Points; Bank of America Shares Tumble After Q3 Results

by Avi Kapoor | Oct 14, 2026

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 400 points on Wednesday. The Dow traded down 0.35% to...

AST SpaceMobile Stock Sinks To 52-Week Low – Here’s Why

by Kaustubh Bagalkote | Oct 14, 2026

AST SpaceMobile, Inc. (NASDAQ:ASTS) stock traded lower Wednesday, extending Tuesday’s decline after Piper Sandler analyst Alexander Potter...

Vir Biotechnology, Gilead Strike Deal for Novel Tumor Treatments

by Vandana Singh | Oct 14, 2026

Vir Biotechnology Inc. (NASDAQ:VIR) announced a major collaboration with Gilead Sciences Inc. (NASDAQ:GILD) to create three novel T-cell engagers...

What’s Going On With Entrada Therapeutics Stock Wednesday?

by Vandana Singh | Oct 14, 2026

On Wednesday, Entrada Therapeutics, Inc. (NASDAQ:TRDA) reported topline results from the first cohort of its Phase 1/2 ELEVATE-45-201 clinical...

Amazon High-Bids for Live Sports Rights to Drive Prime Engagement

by Anusuya Lahiri | Oct 14, 2026

Amazon.com Inc. (NASDAQ:AMZN) is expanding its media strategy across live sports, theatrical films and streaming distribution as Prime Video and...

AEP Unveils $4 Billion Fuel Cell Investment Backed By Long-Term Google Deal

by Lekha Gupta | Oct 14, 2026

American Electric Power Company, Inc. (NASDAQ:AEP) announced Wednesday plans to invest approximately $4 billion in a 702-megawatt fuel cell power...

IREN Stock Tanks: What’s Going On?

by Evette Mitkov | Oct 14, 2026

IREN Ltd (NASDAQ:IREN) shares are falling Wednesday. A spike in CoreWeave’s bond yield has sparked worries about AI financing, and a hot inflation...

3M Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

by Avi Kapoor | Oct 14, 2026

3M Company (NYSE:MMM) will release earnings for its third quarter before the opening bell on Tuesday, Oct. 20. Analysts expect the Saint Paul,...

ASML’s Next Big Chipmaking Cycle Has a Timeline—Intel, Samsung and TSMC Set It

by Surbhi Jain | Oct 14, 2026

ASML Holding N.V.’s (NASDAQ:ASML) next growth cycle may be measured less by how many chipmaking machines it ships today than by when the world’s...

State Street Q3 2026 Earnings Call Transcript

by Benzinga Insights | Oct 14, 2026

State Street (NYSE:STT) released third-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This...

Here’s How Much You Would Have Made Owning Crane Stock In The Last 5 Years

by Benzinga Insights | Oct 14, 2026

Crane (NYSE:CR) has outperformed the market over the past 5 years by 27.95% on an annualized basis producing an average annual return of 39.28%....

« Older Entries
Next Entries »
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Copyright 2019 Karmaholic Media LLC. All Rights Reserved.